SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/23/22 Commonwealth Income & Growth … VI 10-Q 6/30/22 47:1.8M Blueprint/FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 383K 2: EX-31.1 Certification -- §302 - SOA'02 HTML 19K 3: EX-31.2 Certification -- §302 - SOA'02 HTML 19K 4: EX-32.1 Certification -- §906 - SOA'02 HTML 15K 5: EX-32.2 Certification -- §906 - SOA'02 HTML 15K 11: R1 Cover HTML 64K 12: R2 Condensed Balance Sheets HTML 86K 13: R3 Condensed Balance Sheets (Parenthetical) HTML 25K 14: R4 Condensed Statements of Operations (Unaudited) HTML 75K 15: R5 Condensed Statement of Partners' Equity HTML 42K (Unaudited) 16: R6 Condensed Statements of Cash Flow (Unaudited) HTML 30K 17: R7 Business HTML 21K 18: R8 Summary of Significant Accounting Policies HTML 28K 19: R9 Information Technology Medical Technology HTML 26K Telecommunications Technology Inventory Management Equipment (Equipment) 20: R10 Related Party Transactions HTML 34K 21: R11 Notes Payable HTML 29K 22: R12 Supplemental Cash Flow Information HTML 20K 23: R13 Commitments and Contingencies HTML 27K 24: R14 Summary of Significant Accounting Policies HTML 33K (Policies) 25: R15 Summary of Significant Accounting Policies HTML 19K (Tables) 26: R16 Information Technology Medical Technology HTML 21K Telecommunications Technology Inventory Management Equipment (Tables) 27: R17 Related Party Transactions (Tables) HTML 32K 28: R18 Notes Payable (Tables) HTML 26K 29: R19 Supplemental Cash Flow Information (Tables) HTML 19K 30: R20 Business (Details Narrative) HTML 27K 31: R21 Summary of Significant Accounting Policies HTML 20K (Details) 32: R22 Summary of Significant Accounting Policies HTML 19K (Details Narrative) 33: R23 Information Technology Medical Technology HTML 27K Telecommunications Technology Inventory Management Equipment and other BusinessEssential Capital Equipment (Equipment) (Details) 34: R24 Information Technology Medical Technology HTML 25K Telecommunications Technology Inventory Management Equipment and other BusinessEssential Capital Equipment (Equipment) (Details Narrative) 35: R25 Related Party Transactions (Details) HTML 21K 36: R26 Related Party Transactions (Details Narrative) HTML 18K 37: R27 Notes Payable (Details) HTML 26K 38: R28 Notes Payable (Details 1) HTML 26K 39: R29 Notes Payable (Details Narrative) HTML 16K 40: R30 Supplemental Cash Flow Information (Details) HTML 17K 41: R31 Supplemental Cash Flow Information (Details HTML 17K Narrative) 42: R32 Commitments and Contingencies (Details Narrative) HTML 37K 45: XML IDEA XML File -- Filing Summary XML 79K 43: XML XBRL Instance -- cigf_10q_htm XML 305K 44: EXCEL IDEA Workbook of Financial Reports XLSX 61K 8: EX-101.CAL XBRL Calculations -- cigf6-20220630_cal XML 81K 10: EX-101.DEF XBRL Definitions -- cigf6-20220630_def XML 95K 7: EX-101.LAB XBRL Labels -- cigf6-20220630_lab XML 326K 9: EX-101.PRE XBRL Presentations -- cigf6-20220630_pre XML 249K 6: EX-101.SCH XBRL Schema -- cigf6-20220630 XSD 81K 46: JSON XBRL Instance as JSON Data -- MetaLinks 157± 211K 47: ZIP XBRL Zipped Folder -- 0001654954-22-011705-xbrl Zip 93K
EXHIBIT 32.1
32.1 SECTION 1350 CERTIFICATION OF CHIEF EXECUTIVE OFFICER
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Commonwealth Income & Growth Fund VI, (the “Company”) on Form 10-Q for the quarter ended June 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Kimberly A. Springsteen-Abbott, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
| (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
|
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
| |
Chief Executive Officer |
|
|
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 8/23/22 | |||
For Period end: | 6/30/22 | NT 10-Q | ||
List all Filings |